Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:13 PM ET 10-Q
Financial Results Compass Group Diversified Holdings LLC CODI

Compass Group Diversified Holdings Q3 2026 Results: Turns Profitable, Net Income $21.5M

Compass Diversified Holdings reported its Q3 2026 results following a period of significant disruption caused by an internal investigation into its Lugano subsidiary, which resulted in deconsolidation and bankruptcy. The company is currently focused on internal control remediation, deleveraging, and managing professional fees related to the Lugano Investigation while maintaining its 2022 Credit Facility.

Key figure
Net income $21.5M
4:13 PM ET 8-K
Financial Results Motorola Solutions, Inc. MSI

Motorola Solutions Financial Results

Motorola Solutions reported third-quarter 2026 sales of $3.4 billion, up 12% year-over-year, driven by strong demand in safety and security solutions. The company achieved a record ending backlog of $16.6 billion and raised its full-year revenue and earnings outlook for the second time this year.

Term
Q3 2026

“Q3 was another outstanding quarter, with double-digit revenue growth across both segments and all three technologies. We continue to see exceptionally strong demand across our safety and security solutions, driving record Q3 orders and an all-time record ending backlog. As a result, we’re raising our revenue and earnings outlook again and increasing our cash flow expectations for the full year.”

Greg Brown, chairman and CEO, Motorola Solutions
4:13 PM ET Form 4
Insider Selling Arteris, Inc. AIP

Arteris 10% Owner Bayview Legacy LLC Sells $1.82M of Stock

Bayview Legacy LLC, 10% Owner, sold 100,000 shares of Arteris, Inc. at $18.19 to $18.81 a share (average $18.22) in 2 transactions, worth $1.82M in total on Nov 2, 2026. Shares held after the trade: 8,029,071 (-0.1%).

Value
$1.82M
Shares
100,000
Average price
$18.22
Role
10% Owner
Holding change
-0.1%
Trade date
Nov 2, 2026
4:13 PM ET 10-Q
Financial Results TKO Group Holdings, Inc. TKO ▶ Call

TKO Group Holdings Q3 2026 Results: Net Income $98.7M, Up 140.7% YoY

TKO Group Holdings, Inc. filed its 10-Q for the period ending September 30, 2026, following the 2025 Endeavor Asset Acquisition of IMG, On Location, and PBR. The filing highlights the company's dual-class share structure and its dependence on media rights, content distribution agreements, and key executive management.

Key figure
Net income $98.7M · +140.7% YoY
4:13 PM ET 8-K
Financial Results Zevia PBC ZVIA

Zevia PBC Financial Results

Zevia PBC reported Q3 2026 financial results with net sales growing 18.4% year-over-year to $48.3 million, exceeding its previous guidance. The company improved its net loss to $2.2 million and raised its full-year 2026 outlook for both net sales and Adjusted EBITDA.

Term
Q3 2026

“Our better-than-expected third quarter results, combined with strong execution against our key focus areas and encouraging proof points across the business, reinforce our confidence in Zevia’s trajectory. With a stronger foundation, significant liquidity and additional capital, we are entering an exciting new chapter for our business. We believe we now have the resources, momentum and strategic plan to accelerate our growth and create shareholder value over the long term.”

Alexandre Ruberti, President and CEO of Zevia
4:13 PM ET Form 4
Insider Buying Autonation, Inc. AN

Autonation EVP & CFO Thomas A. Szlosek Buys $300K of Stock

Thomas A. Szlosek, EVP & CFO, bought 1,648 shares of Autonation, Inc. at $180.00 to $185.00 a share (average $182.03) in 3 transactions, worth $300K in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 20,085 (+2.8%).

Value
$300K
Shares
1,648
Average price
$182.03
Role
EVP & CFO
Holding change
+2.8%
Trade date
Nov 2, 2026 to Nov 3, 2026
4:13 PM ET 8-K
Leadership Change InvenTrust Properties Corp. IVT

InvenTrust Properties Leadership Change

InvenTrust Properties Corp. increased its Board of Directors from eight to nine members and appointed Robert A. Garechana as an independent director and member of the Audit Committee. Mr. Garechana currently serves as EVP and CFO of Sun Communities, Inc. and previously held senior leadership roles at Equity Residential.

4:13 PM ET Form 4
Insider Selling Dominos Pizza Inc DPZ

Dominos Pizza CEO Joseph Hugh Jordan Sells $1.54M of Stock

Joseph Hugh Jordan, CEO, sold 4,870 shares of Dominos Pizza Inc at $316.50 a share, worth $1.54M in total on Nov 2, 2026. Shares held after the trade: 21,075 (-18.8%).

Value
$1.54M
Shares
4,870
Price
$316.50
Role
CEO
Holding change
-18.8%
Trade date
Nov 2, 2026
4:13 PM ET 8-K
Financial Results Sight Sciences, Inc. SGHT

Sight Sciences Financial Results

Sight Sciences reported record third-quarter 2026 revenue of $24.9 million, a 25% increase year-over-year, driven by significant growth in its Interventional Dry Eye segment. The company improved its net loss to $6.8 million and raised its full-year 2026 revenue guidance to a range of $99.1 million to $101.1 million.

“We delivered another strong quarter with 25% total revenue growth, record IDE revenue, continued IG revenue growth, and a significant reduction in cash burn. These results demonstrate increasing adoption of our technologies, disciplined execution across our organization, and our growing impact on patients with glaucoma and dry eye disease.”

Paul Badawi, Co-Founder and CEO of Sight Sciences
4:13 PM ET 8-K
Financial Results Progyny, Inc. PGNY

Progyny Financial Results

Progyny reported record third-quarter 2026 results with revenue increasing 9% year-over-year to $341.3 million and net income nearly doubling to $26.3 million. The company achieved its strongest selling season ever, adding 1.3 million new covered lives for 2027 while maintaining near 100% client retention.

“We're exceptionally pleased with the results of our most recent selling season, where our momentum extended even into its latest stages, yielding 1.3 million new covered lives, our most ever in a single season, and over 85 new clients.”

Pete Anevski, Chief Executive Officer of Progyny

“We achieved strong top- and bottom-line growth this quarter, reflecting that member engagement was consistent with our expectations, and we are pleased to be in a position to raise the midpoint of our full year guidance.”

Mark Livingston, Chief Financial Officer of Progyny
4:13 PM ET 8-K
Financial Results Caris Life Sciences, Inc. CAI

Caris Life Sciences Financial Results

Caris Life Sciences reported Q3 2026 revenue of $275.4 million, a 27% increase year-over-year, driven by strong molecular profiling clinical case volume. The company raised its full-year 2026 revenue guidance to a range of $1.04 billion to $1.05 billion and reported positive net income of $15.3 million for the quarter.

Term
Q3 2026

“This was another record quarter, with approximately 61,500 clinical cases, up 21% year over year. Every case we run carries real molecular depth, whether Whole Exome, Whole Transcriptome, Whole Genome, or AI-driven digital pathology, and that depth is what allows us to move across the entire cancer journey.”

David Dean Halbert, Founder, Chairman and CEO
4:12 PM ET 8-K
Financial Results American Homes 4 Rent, L.P. AMH

American Homes 4 Rent Financial Results

American Homes 4 Rent (AMH) reported Q3 2026 financial results with total revenues increasing 4.1% year-over-year to $498.1 million. The company raised its full-year 2026 Core FFO guidance midpoint to $1.97 per share and repurchased $75 million of its Class A common shares during the quarter.

Term
Q3 2026

“AMH had another strong quarter with balanced execution across the platform and resilient demand driving an increase to the midpoint of our Core FFO per share guidance by $0.02 to $1.97 – now representing 5.3% year-over-year growth. Our high-quality homes in great locations, superior resident experience supported by our technology and data platform, and outstanding team continue to differentiate AMH and drive sector-leading growth as we close out 2026 and turn our attention to 2027.”

Bryan Smith, AMH’s Chief Executive Officer
4:12 PM ET Form 4
Insider Selling Arteris, Inc. AIP

Arteris President and CEO K. Charles Janac Sells $1.82M of Stock

K. Charles Janac, President and CEO, sold 100,000 shares of Arteris, Inc. at $18.19 to $18.81 a share (average $18.22) in 2 transactions, worth $1.82M in total on Nov 2, 2026. Shares held after the trade: 8,029,071 (-0.1%).

Value
$1.82M
Shares
100,000
Average price
$18.22
Role
President and CEO
Holding change
-0.1%
Trade date
Nov 2, 2026
4:12 PM ET 8-K
Financial Results Stabilis Solutions, Inc. SLNG

Stabilis Solutions Financial Results

Stabilis Solutions reported Q3 2026 revenue of $14.8 million and net income of $0.2 million, marking a sequential recovery from a net loss in the previous quarter. The results were driven by growth in data center-related revenue, which rose to 17% of total revenue, and a 49% year-over-year increase in aerospace sector revenue.

“Our third quarter results were in line with our expectations and reflect the sequential improvement we anticipated, with revenues of $14.8 million supported by execution of a short-term power generation contract secured earlier this year.”

Casey Crenshaw, Executive Chairman and Interim President & Chief Executive Officer

“Demand for small-scale LNG solutions to support behind-the-meter power generation at data centers remains robust, and we continue to pursue additional opportunities in this market that would extend our growth beyond the contracts already in hand.”

Casey Crenshaw, Executive Chairman and Interim President & Chief Executive Officer
4:12 PM ET 10-Q
Financial Results Rapid7, Inc. RPD

Rapid7 Q3 2026 Results: Net Income $3.51M, Down 64.2% YoY

Rapid7 reported a slight decrease in total revenue to $633.0 million for the first nine months of 2026 compared to $642.4 million in 2025. Despite the revenue dip, the company achieved a net income of $10.7 million, supported by a reduction in total operating expenses and a restructuring initiative that incurred $11.7 million in costs.

Key figure
Net income $3.51M · -64.2% YoY
4:12 PM ET 8-K
Financial Results Snap Inc SNAP

Snap Financial Results

Snap Inc. reported third quarter 2026 financial results, achieving a return to profitability with net income of $56 million compared to a net loss in the prior year. Revenue grew 14% year-over-year to $1.72 billion, driven by progress in its advertising platform and AI investments.

Term
Q3 2026

“In Q3, we generated positive net income as revenue grew 14% year-over-year to $1.72 billion, reflecting the progress we are making to build a more profitable business. AI is becoming a significant advantage for our teams and advertising platform, and we continue to strengthen our business while investing in our long-term vision for augmented reality with the launch of SPECS.”

Evan Spiegel, co-founder and CEO
4:12 PM ET 8-K
Financial Results e.l.f. Beauty, Inc. ELF

e.l.f. Beauty Financial Results

e.l.f. Beauty reported second quarter fiscal 2027 net sales of $520.8 million, a 51% increase year-over-year driven by strength in retail and e-commerce channels. The company raised its full-year fiscal 2027 net sales growth guidance to a range of 22% to 24%.

Term
Q2 2027

“I am proud of the e.l.f. Beauty team for delivering our 31st consecutive quarter of net sales growth, with net sales up 51% driven by strength across our portfolio. With this momentum, we are raising our full-year net sales guidance to 22 to 24 percent.”

Tarang Amin, e.l.f. Beauty Chairman and CEO
4:12 PM ET 10-Q
Financial Results Unum Group UNM

Unum Group Q3 2026 Results: Net Loss of $420M

Unum Group reported total assets of $61.3 billion as of September 30, 2026, a decrease from $63.5 billion at year-end 2025. The company maintained a strong equity position of $10.8 billion despite a significant increase in treasury stock holdings, while premium income for the third quarter of 2026 reached $2.8 billion.

Key figure
Net loss $420M
4:12 PM ET 10-Q
Financial Results Omnicell, Inc. OMCL

Omnicell Q3 2026 Results: Net Income $11M, Up 102.2% YoY

Omnicell reported total revenues of $929.9 million for the nine months ended September 30, 2026, a significant increase from $870.9 million in the prior year period. Net income for the same period rose sharply to $46.7 million compared to $4.1 million in 2025, driven by improved gross margins and controlled operating expenses.

Key figure
Net income $11M · +102.2% YoY
4:12 PM ET 10-Q
Financial Results Design Therapeutics, Inc. DSGN

Design Therapeutics Q3 2026 Results: Net Loss of $20.3M, Loss Widens

Design Therapeutics reported a net loss of $20.3 million for the third quarter of 2026, driven by $22.2 million in operating expenses primarily for R&D. The company maintained a strong liquidity position with $208.6 million in cash and investments, which management expects will fund operations for at least 12 months.

Key figure
Net loss $20.3M
4:12 PM ET 10-Q
Financial Results Kailera Therapeutics, Inc. KLRA

Kailera Therapeutics Q3 2026 Results: Net Loss of $95.7M, Loss Widens

Kailera Therapeutics reported a net loss of $285.8 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $256.6 million. During the period, the company completed its initial public offering, raising $662.0 million in net proceeds and ending the quarter with $1.03 billion in total stockholders' equity.

Key figure
Net loss $95.7M
4:12 PM ET 8-K
Financial Results Alpha Teknova, Inc. TKNO

Alpha Teknova Financial Results

Alpha Teknova reported record third quarter 2026 revenue of $12.7 million, a 22% increase year-over-year, driven by strong demand in Clinical Solutions and Lab Essentials. Based on the performance, the company raised its full-year 2026 revenue guidance to a range of $46 million to $48 million.

Term
Q3 2026

“We posted record revenue for the second consecutive quarter. Growth was driven by increased sales of products to life science tools and diagnostics, and to biopharma customers. Notably, there was an increase in purchases of our custom products by small and mid-sized biotech customers and their associated contract manufacturers, which we believe is an early indication of biotech funding improvements over the past four quarters.”

Stephen Gunstream, President and Chief Executive Officer

“We delivered excellent financial results in the third quarter 2026 compared to 2025, highlighted by 22% revenue growth and a significant improvement in Adjusted EBITDA and Free Cash Outflow. We are therefore raising our 2026 revenue guidance to $46-48 million and maintaining our expectations for full-year Free Cash Outflow of less than $8 million.”

Matt Lowell, Chief Financial Officer
4:12 PM ET 8-K
Investor Presentation Southern Missouri Bancorp, Inc. SMBC

Southern Missouri Bancorp Investor Presentation

Southern Missouri Bancorp, Inc. filed an investor presentation to be used at the Hovde Group Financial Services Conference on November 5, 2026. The presentation provides an overview of the company's mission, values, and retail and business banking offerings for the first quarter of fiscal 2027.

4:12 PM ET 8-K
Financial Results Paycom Software, Inc. PAYC

Paycom Software Financial Results

Paycom Software reported third quarter 2026 total revenues of $543.8 million, a 10.2% increase year-over-year, driven by strong growth in recurring revenues. The company achieved GAAP net income of $133.2 million and raised its full-year 2026 revenue guidance to a range of $2.213 billion to $2.218 billion.

Term
Q3 2026

“Our strong third-quarter results reflect the tremendous ROI clients are realizing from the automated decisioning logic built into our platform. Our software and infrastructure allow us to develop, release, host, distribute, and service technology that delivers greater value to our clients and Paycom. This represents a powerful advantage across our large and expanding TAM. Thanks to our strong performance, we are once again raising our full-year outlook.”

Chad Richison, Paycom founder and CEO
4:12 PM ET 8-K
Financial Results Western Midstream Partners, LP WES

Western Midstream Partners Financial Results

Western Midstream Partners reported third-quarter 2026 results featuring record natural-gas throughput of 5.9 Bcf/d and a 12% year-over-year increase in Adjusted EBITDA to $708.3 million. The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $2.75 billion to $2.95 billion while noting that capital expenditures are expected to be slightly above the high end of the $850 million to $1.0 billion range due to accelerated producer activity.

Term
Q3 2026

“WES achieved record natural-gas throughput, partnership-wide and in the Delaware Basin, driven by increased throughput from our legacy assets and a full quarter of contribution from the Brazos Delaware acquisition that closed in June. The Brazos integration is progressing as expected, and we anticipate tying those assets into our West Texas Complex by mid-December, enabling us to reduce offloads and generate more value for WES unitholders.”

Oscar K. Brown, President and Chief Executive Officer
4:12 PM ET 8-K
Financial Results Quinstreet, Inc QNST

Quinstreet Financial Results

QuinStreet reported record fiscal first quarter 2027 results with revenue of $416.7 million, up 46% year-over-year, and net income of $17.0 million. The company raised its full-year fiscal 2027 outlook, citing continued strength in Auto Insurance carrier demand and momentum in its Home Services platform.

Term
Q1 2027

“The September quarter, our fiscal Q1 was another record quarter and a good start to our fiscal year 2027. We grew revenue 46% year-over-year, and we grew adjusted EBITDA 108% year-over-year.”

Doug Valenti, CEO of QuinStreet

“We are raising our outlook for full fiscal year 2027. We now expect full fiscal year 2027 revenue to be between $1.5 and $1.6 billion, and full fiscal year adjusted EBITDA to be between $155 and $165 million.”

Doug Valenti, CEO of QuinStreet
4:12 PM ET 8-K
Financial Results Adma Biologics, Inc. ADMA

Adma Biologics Financial Results

ADMA Biologics reported third quarter 2026 financial results, highlighted by a 5% year-over-year increase in total revenue to $141.1 million and a 37% increase in GAAP net income to $49.9 million. The growth was primarily driven by ASCENIV revenue, which rose 31% to $124.7 million due to expanding physician adoption and patient starts. The company reiterated its full-year 2026 revenue guidance of at least $530 million while increasing its adjusted earnings outlook.

Term
3 months ended September 30, 2026

“Our third quarter results demonstrate ADMA’s ability to translate accelerating ASCENIV demand into substantial earnings growth. ASCENIV revenue increased 31% year-over-year, driven by expanding physician adoption, new patient starts and growing end-user utilization.”

Adam Grossman, President and Chief Executive Officer

“Our expanding real-world health outcomes evidence strengthens ASCENIV’s clinical value proposition among medically complex primary immunodeficiency patients and supports growing commercial adoption. With our yield-enhanced manufacturing capabilities, robust cash generation and disciplined capital allocation, we believe ADMA is well positioned to deliver sustained, profitable growth and long-term stockholder value creation.”

Adam Grossman, President and Chief Executive Officer
4:12 PM ET 8-K
Financial Results Evolus, Inc. EOLS

Evolus Financial Results

Evolus reported Q3 2026 global net revenue of $78.0 million, a 13% increase year-over-year, driven by growth in its Jeuveau toxin and HA gel portfolio. The company achieved its fourth consecutive quarter of positive Adjusted EBITDA at $1.2 million and reaffirmed its full-year 2026 revenue guidance of $330 million to $337 million.

Term
Q3 2026

“Our third quarter results demonstrate the continued strength of our commercial execution and the progress we are making in building a diversified global performance beauty company. Jeuveau® remains a durable growth engine, and our hyaluronic acid (HA) gel portfolio is gaining meaningful share and becoming an increasingly important contributor to the business.”

David Moatazedi, President and Chief Executive Officer

“Along with our commercial progress, we are building a robust innovation pipeline that broadens our long-term opportunity. Our partnership with IBSA to develop and commercialize Profhilo® in the United States establishes the foundation for skin quality as a third category within our facial injectable platform.”

David Moatazedi, President and Chief Executive Officer
4:12 PM ET Form 4
Insider Selling Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals Insider George L. Sing Sells $20.4M of Stock

George L. Sing sold 21,129 shares of Regeneron Pharmaceuticals, Inc. at $960.57 to $970.18 a share (average $964.38) in 9 transactions, worth $20.4M in total on Nov 2, 2026. Shares held after the trade: 25,147 (-0.8%).

Value
$20.4M
Shares
21,129
Average price
$964.38
Holding change
-0.8%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.